NEW YORK (TheStreet) -- CHANGE IN RATINGS
rated new Outperform at Bernstein. $31 price target. Stock is inexpensive, but management will struggle to turn the company around.
Brown & Brown
downgraded at JP Morgan from Neutral to Underweight. $19 price target. New analyst sees little growth potential for the company.
upgraded at RBC to Outperform. $70 price target. Meeting with management confirmed confidence in the company's long-term growth trends.
( EP) estimates, target reduced at Morgan Stanley. Shares of EP now seen reaching $12. Estimates also lowered, to reflect reduced production estimates and rising funding costs. Equal-weight rating.
estimates, target boosted at UBS. Shares now seen reaching $102. Estimates also raised, as management is guidance toward higher sales. Buy rating.
rated new Buy at Jefferies. $22.50 price target. Market is underestimating strength of the company's LCD panel unit shipments.
upgraded at JP Morgan from Neutral to Overweight. $15 price target. Ramp in Blockbuster Express business should drive growth in 2010.
rated new Perform at Oppenheimer. Stock is already pricing in the company's relative operating strength.
rated new Perform at Oppenheimer. Coverage of TJX was started with a Perform rating. Stock is already up 90% year-to-date and has relatively less near-term margin upside potential.
upgraded at Kaufman from Hold to Buy. $20 price target. Display is seeing continued improvement in pricing and demand and checks suggest better search performance.
STOCK COMMENTS / EPS CHANGES
estimates, target lowered at UBS. Shares now seen reaching $24. Estimates also cut, to reflect lower spending from VZ. Neutral rating.
target, estimate boosted at Barclays. AMSC price target lifted to $39 from $36. 2009 EPS estimate maintained at $0.59, 2010 raised to $1.15. Reiterate Equal Weight rating.
numbers lowered at UBS through 2011. Company is realizing higher operating costs. Neutral rating and new $12 price target.
estimates raised at Goldman through 2013. Company is realizing higher margins and sales should continue to recover. Neutral rating and $61 price target.
numbers raised at UBS. Shares now seen reaching $38. Estimates also boosted, to reflect strong expectations for future Pixar and Marvel films. Buy rating.
( ERTS) numbers lowered at Piper. Shares now seen reaching $16.50. Estimates also cut, to reflect lower game sales across the entire industry.
estimates boosted at FBR through 2011. Company likely to use excess capital for acquisitions. Market Perform and $13 price target.
estimates higher at Barclays. GWW 2009 and 2010 EPS estimates boosted to $5.20 and $5.70, respectively. Maintain Equal Weight rating and $105 price target.
target, estimate raised at Credit Suisse Price target to $25 from $20. 2009 EPS estimate set at $2.28, 2010 lifted to $2.40. Maintain Neutral rating.
target, estimate higher at Barclays. Price target to $22 from $16 on strong 2010 guidance. 2009 EPS estimate maintained at $2.27, 2010 raised to $2.20. Reiterate Underweight rating.
numbers increased at Goldman. Shares now seen reaching $28. Estimates also raised, to reflect the retention of the Tricare contract and the potential for stock buybacks. Buy rating.
numbers increased at JP Morgan. Shares of LLL now seen reaching $85. Estimates also boosted, to reflect improved organic growth expectations. Neutral rating.
estimates lowered at Goldman through 2011. Company lowered its guidance at its recent investor meeting. Sell rating and $34 price target.
target cut, estimates upped at Barclays. Price target cut by a dollar to $18. 2010 and 2011 EPS estimates increased to $0.77 and $1.05, respectively. Reiterate Overweight rating.
estimates increased at UBS through 2011. Weak wireless sales will likely offset better industrial demand. Neutral rating and $15.50 price target.
NY Community Bancorp
( NYB) estimates upped at FBR through 2011. Amtrust deal will add to earnings. Outperform rating and $16 price target.
numbers boosted at Morgan Stanley. Estimates were increased through 2011. NGL trends are improving. Underweight rating and new $43 price target.
Owens & Minor
estimates boosted at Goldman through 2011. Company is realizing higher gross margins. Sell rating and $40 price target.
target, estimates boosted at Barclays. Price target raised by 3 dollars to $36 after solid 1Q10 results. 2010 and 2011 EPS estimates raised to $2.13 and $2.44, respectively. Maintain Equal Weight rating.
numbers higher at BofA/Merrill. PRU 2010 operating EPS guidance to $5.70 from $5.40. Maintain Buy rating and $66 price target.
( TLAB) estimates, target reduced at UBS. Shares of TLAB now seen reaching $6. Estimates also cut, to reflect lower spending from VZ. Neutral rating.
United Natural Foods
estimate upped at Barclays. Barclays increased UNFI 2010 EPS estimate to $1.84, 2010 maintained at $1.55. Reiterate Equal Weight rating and $30 price target.
numbers raised at Goldman through 2011. See potential for margin improvement, aided by cost cutting. Buy rating and $83 price target.
This article was written by a staff member of TheStreet.com.